Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by Endo USA Inc., priced at $0.7724 per EA under NDC 49884046565. Its NADAC has been published 653 times since Nov 28, 2013.
FDA first approved this application on Aug 26, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/9g
Manufacturer
Endo USA Inc.NDC
49884046565
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA077204FDA Approved
8/26/2005
TE Code
AB
On Market Since
9/15/2005
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 653 times since Nov 28, 2013, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7724 per EA |
|---|---|
| All-time high | $1.9352 (May 13, 2015) |
| All-time low | $0.5806 (Apr 17, 2024) |
| 52-week high | $0.9390 |
| 52-week low | $0.6721 |
| Median price | $1.3587 |
| Average price | $1.3379 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Endo USA Inc., is $0.7724 per EA (NDC 49884046565), effective Aug 19, 2026.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 52.6%. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Nov 28, 2013, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.9352 (May 13, 2015), with a median of $1.3587 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHOLESTYRAMINE PACKET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 49884046565) is labeled by Endo USA Inc., and CMS classifies it as a generic product.